These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 36816364)
1. Identification of Ultrasound-Sensitive Prognostic Markers of LAML and Construction of Prognostic Risk Model Based on WGCNA. Tian C; Guo H; Wei W J Oncol; 2023; 2023():2353249. PubMed ID: 36816364 [TBL] [Abstract][Full Text] [Related]
2. Construction and validation of a prognostic marker and risk model for HCC ultrasound therapy combined with WGCNA identification. Bi Y; Jing Y; Guo L Front Genet; 2022; 13():1017551. PubMed ID: 36263426 [No Abstract] [Full Text] [Related]
3. Immunological Value of Prognostic Signature Based on Cancer Stem Cell Characteristics in Hepatocellular Carcinoma. Xu Q; Xu H; Chen S; Huang W Front Cell Dev Biol; 2021; 9():710207. PubMed ID: 34409040 [No Abstract] [Full Text] [Related]
4. Comprehensive analysis of immune-related gene signature based on ssGSEA algorithms in the prognosis and immune landscape of hepatocellular carcinoma. Wang L; Wang L; He P Front Genet; 2022; 13():1064432. PubMed ID: 36568383 [No Abstract] [Full Text] [Related]
5. Integrating multiple machine learning algorithms for prognostic prediction of gastric cancer based on immune-related lncRNAs. Li G; Huo D; Guo N; Li Y; Ma H; Liu L; Xie H; Zhang D; Qu B; Chen X Front Genet; 2023; 14():1106724. PubMed ID: 37082204 [No Abstract] [Full Text] [Related]
6. Identification of prognostic cancer-associated fibroblast markers in luminal breast cancer using weighted gene co-expression network analysis. Xu A; Xu XN; Luo Z; Huang X; Gong RQ; Fu DY Front Oncol; 2023; 13():1191660. PubMed ID: 37207166 [TBL] [Abstract][Full Text] [Related]
7. Construction and validation of a bladder cancer risk model based on autophagy-related genes. Shen C; Yan Y; Yang S; Wang Z; Wu Z; Li Z; Zhang Z; Lin Y; Li P; Hu H Funct Integr Genomics; 2023 Jan; 23(1):46. PubMed ID: 36689018 [TBL] [Abstract][Full Text] [Related]
8. Systematic Analysis and Identification of Molecular Subtypes of TRP-Related Genes and Prognosis Prediction in Lung Adenocarcinoma. Guo Y; Liu N J Oncol; 2022; 2022():5388283. PubMed ID: 36090899 [TBL] [Abstract][Full Text] [Related]
9. Integration of scRNA-Seq and Bulk RNA-Seq to Analyse the Heterogeneity of Ovarian Cancer Immune Cells and Establish a Molecular Risk Model. Liang L; Yu J; Li J; Li N; Liu J; Xiu L; Zeng J; Wang T; Wu L Front Oncol; 2021; 11():711020. PubMed ID: 34621670 [TBL] [Abstract][Full Text] [Related]
10. A transient receptor potential channel-related model based on machine learning for evaluating tumor microenvironment and immunotherapeutic strategies in acute myeloid leukemia. Hua J; Ding T; Shao Y Front Immunol; 2022; 13():1040661. PubMed ID: 36591215 [TBL] [Abstract][Full Text] [Related]
11. Identification of ferroptosis genes in immune infiltration and prognosis in thyroid papillary carcinoma using network analysis. Lin R; Fogarty CE; Ma B; Li H; Ni G; Liu X; Yuan J; Wang T BMC Genomics; 2021 Jul; 22(1):576. PubMed ID: 34315405 [TBL] [Abstract][Full Text] [Related]
12. Prognosis and therapy in thyroid cancer by gene signatures related to natural killer cells. Jin Z; Han Y; Zhang J; Liu Z; Li R; Liu Z J Gene Med; 2024 Jan; 26(1):e3657. PubMed ID: 38282150 [TBL] [Abstract][Full Text] [Related]
13. Characterization and application of a lactate and branched chain amino acid metabolism related gene signature in a prognosis risk model for multiple myeloma. Yu Z; Qiu B; Zhou H; Li L; Niu T Cancer Cell Int; 2023 Aug; 23(1):169. PubMed ID: 37580667 [TBL] [Abstract][Full Text] [Related]
14. An Intratumor Heterogeneity-Related Signature for Predicting Prognosis, Immune Landscape, and Chemotherapy Response in Colon Adenocarcinoma. Liu C; Liu D; Wang F; Xie J; Liu Y; Wang H; Rong J; Xie J; Wang J; Zeng R; Zhou F; Xie Y Front Med (Lausanne); 2022; 9():925661. PubMed ID: 35872794 [TBL] [Abstract][Full Text] [Related]
15. Identification of Stemness Characteristics Associated With the Immune Microenvironment and Prognosis in Gastric Cancer. Mao D; Zhou Z; Song S; Li D; He Y; Wei Z; Zhang C Front Oncol; 2021; 11():626961. PubMed ID: 33747944 [TBL] [Abstract][Full Text] [Related]
16. Establishment of an ovarian cancer omentum metastasis-related prognostic model by integrated analysis of scRNA-seq and bulk RNA-seq. Zhang D; Lu W; Cui S; Mei H; Wu X; Zhuo Z J Ovarian Res; 2022 Nov; 15(1):123. PubMed ID: 36424614 [TBL] [Abstract][Full Text] [Related]
17. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer. Wang J; Qin D; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Zhong S; Hu X Front Immunol; 2022; 13():1056932. PubMed ID: 36479114 [TBL] [Abstract][Full Text] [Related]
18. Comprehensive Xu T; Xu W; Zheng Y; Li X; Cai H; Xu Z; Zou Q; Yu B Front Immunol; 2022; 13():931906. PubMed ID: 35958598 [TBL] [Abstract][Full Text] [Related]
19. Identification of the Real Hub Gene and Construction of a Novel Prognostic Signature for Pancreatic Adenocarcinoma Based on the Weighted Gene Co-expression Network Analysis and Least Absolute Shrinkage and Selection Operator Algorithms. Yuan Q; Ren J; Wang Z; Ji L; Deng D; Shang D Front Genet; 2021; 12():692953. PubMed ID: 34490033 [No Abstract] [Full Text] [Related]
20. Weighted Gene Co-expression Network Analysis Identifies a Cancer-Associated Fibroblast Signature for Predicting Prognosis and Therapeutic Responses in Gastric Cancer. Zheng H; Liu H; Li H; Dou W; Wang X Front Mol Biosci; 2021; 8():744677. PubMed ID: 34692770 [No Abstract] [Full Text] [Related] [Next] [New Search]